United States · 
Who invested in OncoMyx Therapeutics?
OncoMyx Therapeutics's investors include Boehringer Ingelheim Venture Fund, Delos Capital, Xeraya Capital, B Capital and Korea Investment Partners, and 2 more on record.
20202021
$25MSeries A$50MSeries B
United States · Series B startup
Who invested in OncoMyx Therapeutics
Funding summaryUpdated 26 Oct 2026
$75Mraised across 2 rounds since 2019, from 2 sources
$25MSeries A$50MSeries B
- Latest round
- Series B, $50MDec 2021
- Step-upi
- 2×
- Investors
- 7 (3 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $25M Jun 2019
- Biggest round
- $50M Series B · Dec 2021
- Between rounds
- 2.5 years from the last two
The rounds
- Dec 2021Series B$50M2 new1 returning
Source recordedSEC filing: $50M sold, first sale Nov 2021
- Jun 2019Series A$25M5 new
- Boehringer Ingelheim Venture FundLead
Delos CapitalLead
Xeraya CapitalLead
City Hill Ventures
Madison Capital Partners
Reported by FinSMEsSEC filing: $8.0M sold, first sale Jun 2019
Founders and team
From the SEC filings it signed: 2 on the team.
- Leslie M. SharpExecutive Officeri
- Steven J. PottsExecutive Officer, Directori
On the board, as filediBenjamin J. RovinskiCharles M. BaumKanad J. DasTing J. XiaoWidya J. Mulyasasmita
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Boehringer Ingelheim Venture FundCorporate VC2rounds, led 1
Missing a round, or an investor who was in one? Tell us.
Quick answers about OncoMyx Therapeutics
How much has OncoMyx Therapeutics raised?
OncoMyx Therapeutics has raised $75M across 2 rounds since 2019.
When did OncoMyx Therapeutics last raise?
OncoMyx Therapeutics's most recent round was a Series B of $50M in Dec 2021.
What was OncoMyx Therapeutics's biggest round?
Its most recent round, $50M in Dec 2021, is also its largest on record.
Who backed OncoMyx Therapeutics first?
OncoMyx Therapeutics's first round on record, in Jun 2019, was backed by Boehringer Ingelheim Venture Fund, Delos Capital and Xeraya Capital and 2 others.
What stage is OncoMyx Therapeutics at?
OncoMyx Therapeutics's latest named round is a Series B, in Dec 2021.
Where is OncoMyx Therapeutics based?
OncoMyx Therapeutics is based in the United States.
Who led OncoMyx Therapeutics's rounds?
Boehringer Ingelheim Venture Fund led the Series A in 2019.
Companies like OncoMyx Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.